Method for the treatment of radiation-induced neutropenia by administration of a multi-PEGylated granulocyte colony stimulating factor (G-CSF) variant

Details for Australian Patent Application No. 2009293025 (hide)

Owner Maxygen, Inc.

Inventors Yonehiro, Grant; Macvittie, Thomas J.

Agent Spruson & Ferguson

Pub. Number AU-A-2009293025

PCT Pub. Number WO2010/033884

Priority 61/098,569 19.09.08 US

Filing date 18 September 2009

Wipo publication date 25 March 2010

International Classifications

C07K 14/535 (2006.01) Peptides having more than 20 amino acids

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

14 April 2011 PCT application entered the National Phase

  PCT publication WO2010/033884 Priority application(s): WO2010/033884

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009293027-System and method for scene change triggering

2009293024-Battery exchange station